Review



ncam1  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    R&D Systems ncam1
    Ncam1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ncam1/product/R&D Systems
    Average 93 stars, based on 6 article reviews
    ncam1 - by Bioz Stars, 2026-05
    93/100 stars

    Images



    Similar Products

    ncam1  (R&D Systems)
    93
    R&D Systems ncam1
    Ncam1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ncam1/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    ncam1 - by Bioz Stars, 2026-05
    93/100 stars
    		  Buy from Supplier
    cd56  (Cell Signaling Technology Inc)
    95
    Cell Signaling Technology Inc cd56
    Cd56, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd56/product/Cell Signaling Technology Inc
    Average 95 stars, based on 1 article reviews
    cd56 - by Bioz Stars, 2026-05
    95/100 stars
    		  Buy from Supplier
    rabbit anti ncam1  (Proteintech)
    94
    Proteintech rabbit anti ncam1
    Rabbit Anti Ncam1, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti ncam1/product/Proteintech
    Average 94 stars, based on 1 article reviews
    rabbit anti ncam1 - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    cd56  (Proteintech)
    94
    Proteintech cd56
    In vivo evaluation properties of HMnO 2 @CaO 2 in K7M2-tumor-bearing mice. (a) Schematic representation of a tumor metastasis model and corresponding treatment strategy. (b) Images of primary tumors from mice following a 21-day treatment period. (c) Tumor volume curves after different treatments. (d) Body weight changes after 21-day treatment period. (e) H&E and Ki67 (red) stained after different treatments, scale bar = 100 μm. (f) Corresponding fluorescence intensity of GRP78 and (g) GPX4. (h) Immunofluorescence staining results of GRP78 and GPX4, scale bar = 50 μm. (i) Immunofluorescence staining results of iNOS (red), and immunohistochemical staining results of Arg-1 (yellow), scale bar = 100 μm. (j) The image of CD8 + T cells in the tumor after various treatment, scale bar = 100 nm. (k) The level of CD8 + cells in different treatments. The cytokines secretion of (l) IFN-γ and (m) IL-6 in serum after different treatments. (n) The CLSM of <t>CD56</t> and CD16, scale bar = 100 nm. (o) The level of NK cells after different treatments.
    Cd56, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd56/product/Proteintech
    Average 94 stars, based on 1 article reviews
    cd56 - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    cd16  (Proteintech)
    94
    Proteintech cd16
    In vivo evaluation properties of HMnO 2 @CaO 2 in K7M2-tumor-bearing mice. (a) Schematic representation of a tumor metastasis model and corresponding treatment strategy. (b) Images of primary tumors from mice following a 21-day treatment period. (c) Tumor volume curves after different treatments. (d) Body weight changes after 21-day treatment period. (e) H&E and Ki67 (red) stained after different treatments, scale bar = 100 μm. (f) Corresponding fluorescence intensity of GRP78 and (g) GPX4. (h) Immunofluorescence staining results of GRP78 and GPX4, scale bar = 50 μm. (i) Immunofluorescence staining results of iNOS (red), and immunohistochemical staining results of Arg-1 (yellow), scale bar = 100 μm. (j) The image of CD8 + T cells in the tumor after various treatment, scale bar = 100 nm. (k) The level of CD8 + cells in different treatments. The cytokines secretion of (l) IFN-γ and (m) IL-6 in serum after different treatments. (n) The CLSM of CD56 and <t>CD16,</t> scale bar = 100 nm. (o) The level of NK cells after different treatments.
    Cd16, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd16/product/Proteintech
    Average 94 stars, based on 1 article reviews
    cd16 - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    cd8  (Proteintech)
    94
    Proteintech cd8
    In vivo evaluation properties of HMnO 2 @CaO 2 in K7M2-tumor-bearing mice. (a) Schematic representation of a tumor metastasis model and corresponding treatment strategy. (b) Images of primary tumors from mice following a 21-day treatment period. (c) Tumor volume curves after different treatments. (d) Body weight changes after 21-day treatment period. (e) H&E and Ki67 (red) stained after different treatments, scale bar = 100 μm. (f) Corresponding fluorescence intensity of GRP78 and (g) GPX4. (h) Immunofluorescence staining results of GRP78 and GPX4, scale bar = 50 μm. (i) Immunofluorescence staining results of iNOS (red), and immunohistochemical staining results of Arg-1 (yellow), scale bar = 100 μm. (j) The image of <t>CD8</t> + T cells in the tumor after various treatment, scale bar = 100 nm. (k) The level of CD8 + cells in different treatments. The cytokines secretion of (l) IFN-γ and (m) IL-6 in serum after different treatments. (n) The CLSM of CD56 and CD16, scale bar = 100 nm. (o) The level of NK cells after different treatments.
    Cd8, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd8/product/Proteintech
    Average 94 stars, based on 1 article reviews
    cd8 - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    mouse anti cd56  (Proteintech)
    94
    Proteintech mouse anti cd56
    In vivo evaluation properties of HMnO 2 @CaO 2 in K7M2-tumor-bearing mice. (a) Schematic representation of a tumor metastasis model and corresponding treatment strategy. (b) Images of primary tumors from mice following a 21-day treatment period. (c) Tumor volume curves after different treatments. (d) Body weight changes after 21-day treatment period. (e) H&E and Ki67 (red) stained after different treatments, scale bar = 100 μm. (f) Corresponding fluorescence intensity of GRP78 and (g) GPX4. (h) Immunofluorescence staining results of GRP78 and GPX4, scale bar = 50 μm. (i) Immunofluorescence staining results of iNOS (red), and immunohistochemical staining results of Arg-1 (yellow), scale bar = 100 μm. (j) The image of <t>CD8</t> + T cells in the tumor after various treatment, scale bar = 100 nm. (k) The level of CD8 + cells in different treatments. The cytokines secretion of (l) IFN-γ and (m) IL-6 in serum after different treatments. (n) The CLSM of CD56 and CD16, scale bar = 100 nm. (o) The level of NK cells after different treatments.
    Mouse Anti Cd56, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti cd56/product/Proteintech
    Average 94 stars, based on 1 article reviews
    mouse anti cd56 - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    In vivo evaluation properties of HMnO 2 @CaO 2 in K7M2-tumor-bearing mice. (a) Schematic representation of a tumor metastasis model and corresponding treatment strategy. (b) Images of primary tumors from mice following a 21-day treatment period. (c) Tumor volume curves after different treatments. (d) Body weight changes after 21-day treatment period. (e) H&E and Ki67 (red) stained after different treatments, scale bar = 100 μm. (f) Corresponding fluorescence intensity of GRP78 and (g) GPX4. (h) Immunofluorescence staining results of GRP78 and GPX4, scale bar = 50 μm. (i) Immunofluorescence staining results of iNOS (red), and immunohistochemical staining results of Arg-1 (yellow), scale bar = 100 μm. (j) The image of CD8 + T cells in the tumor after various treatment, scale bar = 100 nm. (k) The level of CD8 + cells in different treatments. The cytokines secretion of (l) IFN-γ and (m) IL-6 in serum after different treatments. (n) The CLSM of CD56 and CD16, scale bar = 100 nm. (o) The level of NK cells after different treatments.

    Journal: Journal of Advanced Research

    Article Title: Ion interference induced by Ca-Mn nanoplatform enhances ferroptosis and promotes immune response for osteosarcoma treatment

    doi: 10.1016/j.jare.2025.06.022

    Figure Lengend Snippet: In vivo evaluation properties of HMnO 2 @CaO 2 in K7M2-tumor-bearing mice. (a) Schematic representation of a tumor metastasis model and corresponding treatment strategy. (b) Images of primary tumors from mice following a 21-day treatment period. (c) Tumor volume curves after different treatments. (d) Body weight changes after 21-day treatment period. (e) H&E and Ki67 (red) stained after different treatments, scale bar = 100 μm. (f) Corresponding fluorescence intensity of GRP78 and (g) GPX4. (h) Immunofluorescence staining results of GRP78 and GPX4, scale bar = 50 μm. (i) Immunofluorescence staining results of iNOS (red), and immunohistochemical staining results of Arg-1 (yellow), scale bar = 100 μm. (j) The image of CD8 + T cells in the tumor after various treatment, scale bar = 100 nm. (k) The level of CD8 + cells in different treatments. The cytokines secretion of (l) IFN-γ and (m) IL-6 in serum after different treatments. (n) The CLSM of CD56 and CD16, scale bar = 100 nm. (o) The level of NK cells after different treatments.

    Article Snippet: The primary antibodies used were CD16 (#DF7007, Affinity), CD56 (60238–1-Ig, Proteintech), and CD8 (#AF5126, Affinity).

    Techniques: In Vivo, Staining, Fluorescence, Immunofluorescence, Immunohistochemical staining

    In vivo evaluation properties of HMnO 2 @CaO 2 in K7M2-tumor-bearing mice. (a) Schematic representation of a tumor metastasis model and corresponding treatment strategy. (b) Images of primary tumors from mice following a 21-day treatment period. (c) Tumor volume curves after different treatments. (d) Body weight changes after 21-day treatment period. (e) H&E and Ki67 (red) stained after different treatments, scale bar = 100 μm. (f) Corresponding fluorescence intensity of GRP78 and (g) GPX4. (h) Immunofluorescence staining results of GRP78 and GPX4, scale bar = 50 μm. (i) Immunofluorescence staining results of iNOS (red), and immunohistochemical staining results of Arg-1 (yellow), scale bar = 100 μm. (j) The image of CD8 + T cells in the tumor after various treatment, scale bar = 100 nm. (k) The level of CD8 + cells in different treatments. The cytokines secretion of (l) IFN-γ and (m) IL-6 in serum after different treatments. (n) The CLSM of CD56 and CD16, scale bar = 100 nm. (o) The level of NK cells after different treatments.

    Journal: Journal of Advanced Research

    Article Title: Ion interference induced by Ca-Mn nanoplatform enhances ferroptosis and promotes immune response for osteosarcoma treatment

    doi: 10.1016/j.jare.2025.06.022

    Figure Lengend Snippet: In vivo evaluation properties of HMnO 2 @CaO 2 in K7M2-tumor-bearing mice. (a) Schematic representation of a tumor metastasis model and corresponding treatment strategy. (b) Images of primary tumors from mice following a 21-day treatment period. (c) Tumor volume curves after different treatments. (d) Body weight changes after 21-day treatment period. (e) H&E and Ki67 (red) stained after different treatments, scale bar = 100 μm. (f) Corresponding fluorescence intensity of GRP78 and (g) GPX4. (h) Immunofluorescence staining results of GRP78 and GPX4, scale bar = 50 μm. (i) Immunofluorescence staining results of iNOS (red), and immunohistochemical staining results of Arg-1 (yellow), scale bar = 100 μm. (j) The image of CD8 + T cells in the tumor after various treatment, scale bar = 100 nm. (k) The level of CD8 + cells in different treatments. The cytokines secretion of (l) IFN-γ and (m) IL-6 in serum after different treatments. (n) The CLSM of CD56 and CD16, scale bar = 100 nm. (o) The level of NK cells after different treatments.

    Article Snippet: The primary antibodies used were CD16 (#DF7007, Affinity), CD56 (60238–1-Ig, Proteintech), and CD8 (#AF5126, Affinity).

    Techniques: In Vivo, Staining, Fluorescence, Immunofluorescence, Immunohistochemical staining

    In vivo evaluation properties of HMnO 2 @CaO 2 in K7M2-tumor-bearing mice. (a) Schematic representation of a tumor metastasis model and corresponding treatment strategy. (b) Images of primary tumors from mice following a 21-day treatment period. (c) Tumor volume curves after different treatments. (d) Body weight changes after 21-day treatment period. (e) H&E and Ki67 (red) stained after different treatments, scale bar = 100 μm. (f) Corresponding fluorescence intensity of GRP78 and (g) GPX4. (h) Immunofluorescence staining results of GRP78 and GPX4, scale bar = 50 μm. (i) Immunofluorescence staining results of iNOS (red), and immunohistochemical staining results of Arg-1 (yellow), scale bar = 100 μm. (j) The image of CD8 + T cells in the tumor after various treatment, scale bar = 100 nm. (k) The level of CD8 + cells in different treatments. The cytokines secretion of (l) IFN-γ and (m) IL-6 in serum after different treatments. (n) The CLSM of CD56 and CD16, scale bar = 100 nm. (o) The level of NK cells after different treatments.

    Journal: Journal of Advanced Research

    Article Title: Ion interference induced by Ca-Mn nanoplatform enhances ferroptosis and promotes immune response for osteosarcoma treatment

    doi: 10.1016/j.jare.2025.06.022

    Figure Lengend Snippet: In vivo evaluation properties of HMnO 2 @CaO 2 in K7M2-tumor-bearing mice. (a) Schematic representation of a tumor metastasis model and corresponding treatment strategy. (b) Images of primary tumors from mice following a 21-day treatment period. (c) Tumor volume curves after different treatments. (d) Body weight changes after 21-day treatment period. (e) H&E and Ki67 (red) stained after different treatments, scale bar = 100 μm. (f) Corresponding fluorescence intensity of GRP78 and (g) GPX4. (h) Immunofluorescence staining results of GRP78 and GPX4, scale bar = 50 μm. (i) Immunofluorescence staining results of iNOS (red), and immunohistochemical staining results of Arg-1 (yellow), scale bar = 100 μm. (j) The image of CD8 + T cells in the tumor after various treatment, scale bar = 100 nm. (k) The level of CD8 + cells in different treatments. The cytokines secretion of (l) IFN-γ and (m) IL-6 in serum after different treatments. (n) The CLSM of CD56 and CD16, scale bar = 100 nm. (o) The level of NK cells after different treatments.

    Article Snippet: The primary antibodies used were CD16 (#DF7007, Affinity), CD56 (60238–1-Ig, Proteintech), and CD8 (#AF5126, Affinity).

    Techniques: In Vivo, Staining, Fluorescence, Immunofluorescence, Immunohistochemical staining